ConductScience.org, home

Gene · 406920

MIR130B: microRNA 130b

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MIR130B: microRNA 130b. Genes, record 406920. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/406920

On this page

Gene

Symbol
MIR130B
HGNC
Name
microRNA 130b
HGNC
NCBI Gene ID
406920
NCBI Gene
HGNC ID
HGNC:31515
HGNC
Ensembl
ENSG00000283871
NCBI Gene
Aliases
MIRN130B, hsa-mir-130b, mir-130b
NCBI Gene
Type
ncRNA
NCBI Gene

Proteins0

Reviewed human proteins whose Swiss-Prot entry states the gene.

None in this release.

Patents0

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

None in this release.

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants806

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMIR130B papersNewest fiscal year
P30CA016672Cancer Center Support Grant172025
P50CA127001SPORE in Brain Cancer52025
ZIAAG000393Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging52025
P30CA016058Cancer Center Support Grant42025
P30CA023074University of Arizona Cancer Center - Cancer Center Support Grant42025
P30CA008748Cancer Center Support Grant32025
P30DK078392Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease32025
I01BX000319Ischemic Kidney Injury and Kidney Repair: Stress Granules22025
P30AG028740University of Florida Older Americans Independence Center (OAIC)22025
P30CA016042Cancer Center Support Grant22025

1 to 10 of 806Source NIH's project files

See all 806 nih grants

Papers2,391

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Evaluation of Candidate Urinary microRNAs in Upper Tract Urothelial Carcinoma: A Prospective Multicenter Biomarker Study (JCOG1403A1).Genes (Basel)202642793039PubTator, text miningPubMed
Genetic association of rs373001 polymorphism in mir-130b gene with susceptibility to dyslipidaemia and correlation with lipid profile.J Pak Med Assoc202642444221PubTator, text miningPubMed
Targeting mir130b-IL-33-PD-L1 axis effectively inhibits esophageal squamous carcinoma progression.Transl Oncol202642092279PubTator, text miningPubMed
SMR Peptide Modulates Tumor-Derived Extracellular Vesicles microRNA and Inflammatory Transcript Signatures in TNBC.Cells202641892339PubTator, text miningPubMed
HIF-1α suppresses SNPH expression to facilitate liver metastasis of colorectal cancer through regulating mitochondrial dynamics and filopodia formation.Cell Death Dis202641888092PubTator, text miningPubMed
Short and Long Non-Coding RNAs in Renal Cell Carcinoma.Noncoding RNA202641874142PubTator, text miningPubMed
Type 2 diabetes mellitus associated microRNAs in tuberculosis susceptibility: a systematic review and bioinformatic analysis.Front Endocrinol (Lausanne)202641809532PubTator, text miningPubMed
MicroRNA signatures associated with radioiodine refractoriness and tumor dedifferentiation in metastatic papillary thyroid carcinoma.Endocrine202641801518PubTator, text miningPubMed
The role of miRNAs in the development of brain metastases originating from lung adenocarcinoma.Front Genet202641799343PubTator, text miningPubMed
Ssc-miR-130b Inhibits Lipid Accumulation in Porcine Intramuscular Preadipocytes by Activating Apoptosis via Bcl-2/Bax/Caspase-3 Signaling Pathway.Anim Sci J202641793154PubTator, text miningPubMed

1 to 10 of 2,391

See all 2,391 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/406920

GET https://conductscience.org/api/genes/v1/406920/grants?page=2